tiprankstipranks
Trending News
More News >
Concord Biotech Ltd. (IN:CONCORDBIO)
:CONCORDBIO
India Market

Concord Biotech Ltd. (CONCORDBIO) Income Statement

Compare
2 Followers

Concord Biotech Ltd. Income Statement

Last quarter (Q1 2026), Concord Biotech Ltd.'s total revenue was ₹2.04B, a decrease of -5.47% from the same quarter last year. In Q1, Concord Biotech Ltd.'s net income was ₹440.58M. See Concord Biotech Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 12.00B₹ 10.17B₹ 8.53B₹ 7.13B₹ 6.17B
Gross Profit
₹ 7.68B₹ 6.67B₹ 6.61B₹ 5.41B₹ 5.00B
Operating Expenses
₹ 1.66B₹ 1.46B₹ 1.43B₹ 1.25B₹ 699.61M
Depreciation and Amortization
₹ 526.08M₹ 518.51M₹ 527.85M₹ 487.98M₹ 263.27M
EBITDA
₹ 5.13B₹ 4.39B₹ 3.53B₹ 2.78B₹ 3.29B
Operating Income
₹ 6.02B₹ 5.21B₹ 5.18B₹ 4.16B₹ 4.30B
Other Income/Expenses
₹ -1.07B₹ -1.09B₹ -1.96B₹ -1.79B₹ -1.17B
Pretax Income
₹ 4.95B₹ 4.13B₹ 3.22B₹ 2.38B₹ 3.13B
Net Income
₹ 3.72B₹ 3.08B₹ 2.40B₹ 1.75B₹ 2.35B
Per Share Metrics
Basic EPS
₹ 35.52₹ 29.45₹ 22.95₹ 16.72₹ 22.45
Diluted EPS
₹ 35.52₹ 29.45₹ 22.95₹ 16.72₹ 22.45
Weighted Average Shares Outstanding
104.62M 104.62M 104.62M 104.62M 104.63M
Weighted Average Shares Outstanding (Diluted)
104.62M 104.62M 104.62M 104.62M 104.62M
Currency in INR

Concord Biotech Ltd. Earnings and Revenue History